Bioventus Inc.BVSNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank62
3Y CAGR-68.6%
5Y CAGR+3.4%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-68.6%/yr
vs +57.4%/yr prior
5Y CAGR
+3.4%/yr
Recent deceleration
Acceleration
-126.0pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 26.15% |
| Q3 2025 | 16.04% |
| Q2 2025 | 234.18% |
| Q1 2025 | -200.05% |
| Q4 2024 | 87.30% |
| Q3 2024 | -31.96% |
| Q2 2024 | 352.49% |
| Q1 2024 | -157.89% |
| Q4 2023 | 224.76% |
| Q3 2023 | -177.03% |
| Q3 2023 | 333.53% |
| Q2 2023 | -52.52% |
| Q4 2022 | 848.07% |
| Q4 2022 | -123.85% |
| Q3 2022 | 113.98% |
| Q2 2022 | -260.24% |
| Q4 2021 | 23.90% |
| Q4 2021 | -38.91% |
| Q3 2021 | 196.05% |
| Q2 2021 | -170.90% |
| Q4 2020 | 22.10% |
| Q3 2020 | 166.51% |
| Q2 2020 | -55.80% |
| Q1 2020 | -15.95% |
| Q4 2019 | 79.78% |
| Q3 2019 | 194.18% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2015 | 0.00% |